FDA approves Avadel Pharmaceuticals' once-nightly dosing sleep disorder drug, Lumryz, for children aged 7 years and older, offering a new option for narcolepsy treatment.
A study of over 36,000 patients revealed 25% of asthma patients and 21.6% of COPD patients switched from dry powder inhalers to pressurized metered-dose inhalers in the previous year, highlighting significant device changes in real-world practice.
Discover the concerning racial bias in pulse oximeters' readings, impacting patient care and outcomes, and the ongoing efforts to address this critical issue. #Healthcare #RacialBias
New research reveals tropical cyclones may have caused 3.6 to 5.7 million excess deaths in the U.S. from 1930-2015, far exceeding official estimates and contributing to 3.2-5.1% of all deaths nationwide.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Study reveals 37.9% of single emerging adults are relatively happy, challenging stereotypes and highlighting the crucial role of friendship satisfaction in their well-being.
Social media fuels mouth taping trend with 7 million TikTok views, prompting medical experts to scrutinize limited data on forced mouth closure during sleep.
A recent study compared the effects of 24-hour versus 15-hour long-term oxygen therapy in patients with severe hypoxemia, finding no significant advantage of the former over the latter.
New analysis reveals U.S. nonprofit hospitals received $37.4 billion in tax benefits in 2021, with more than half attributed to state and local taxes. The benefits varied significantly by state and were concentrated among a small number of hospitals.